The evolving healthcare landscape, influenced by factors such as expanded health insurance coverage from the Affordable Care Act, rising acute and chronic illness rates, and modernization of healthcare facilities, is driving growth in medical imaging products. While cost containment efforts may impact pricing, tests improving therapeutic outcomes are expected to thrive. In Kalorama Information’s report […]
Telemedicine to address the growing need for mental health monitoring and intervention is one of several market opportunities that offer intriguing benefits over traditional office-based care. Also known as teletherapy (as well as telemental health, telehealth therapy, or telepsychiatry), this specific form of telemedicine is an area where interest has increased significantly, as barriers to […]
Digitally-enabled care, including remote patient monitoring and telehealth/telemedicine, is taking center stage in the healthcare environment. Nearly $66 billion was spent on patient monitoring and telehealth equipment, devices, and services worldwide during 2023, up from $46 billion in 2018, reports leading medical market researcher Kalorama Information in the new report, Remote Patient Monitoring and Telehealth […]
“Advances in Medtech can enhance patient treatment, improve outcomes, lower hospital admissions and fatalities, achieve cost savings, and alleviate the workload on healthcare staff, thus creating a market for medical devices that is forecast to grow and expand over the next five years.“ – Kalorama Information The world market for Medtech is valued at over $500 billion […]
COVID-19, mergers & acquisitions, and innovation spurred notable gains in the sale of medical devices in 2020 The global market for medical devices rose to $472 billion in 2020, increasing 5.1% for the year over 2019, according to new data published in The Global Market for Medical Devices, 11th Edition, the latest report […]
Coagulation is a complex process in which multiple enzymes and proteins regulate blood flow and clot formation. Coagulation (clot formation), fibrinolysis and platelet aggregation are a part of this process. Fibrinolysis refers to the breakup of blood clots. It is a normal body process that keeps naturally occurring blood clots from growing and causing problems. Anticoagulant drugs help prevent blood platelets from sticking or clumping together, reducing the likelihood that arteries will be blocked by a clot, leading to a stroke or heart attack.
This article is based on information from Kalorama’s partner publication IMV (http://www.imvinfo.com), a premier source of information for the radiology industry. In the 1980s, CT and MR scanners revolutionized the imaging industry by generating images digitally rather than using analog/film-based technology. Since then, radiology/imaging departments have progressed to being almost fully digitally based, with the […]
In many ways, the IVD market of today does not resemble the market five years ago. 2018 appears to be the year where a number of trends that had been discussed began to gel. With that in mind, Kalorama Information will be on hand for UBM’s BIOMedDevice Convention in San Jose, CA next month. In […]
